Sonnet BioTherapeutics Holdings, Inc. Annual Operating Income (Loss) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$2.85M, a 123% decline year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$13.4M, a 7.19% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Income (Loss) for 2024 was -$11.8M, a 36.9% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$18.8M, a 36.7% increase from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$29.7M, a 18.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.8M +$6.94M +36.9% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-17
2023 -$18.8M +$10.9M +36.7% Oct 1, 2022 Sep 30, 2023 10-K 2024-12-17
2022 -$29.7M -$4.58M -18.3% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-14
2021 -$25.1M -$850K -3.51% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-15
2020 -$24.2M -$8.16M -50.7% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2019 -$16.1M -$10.7M -199% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-19
2018 -$5.37M -$134K -2.56% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$5.24M -$2.62M -99.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$2.62M +$2.46M +48.4% Jan 1, 2016 Dec 31, 2016 10-Q 2018-05-15
2015 -$5.08M +$465K +8.38% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$5.54M -$938K -20.4% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-31
2013 -$4.61M -$2.01M -77.7% Jan 1, 2013 Dec 31, 2013 10-K 2015-04-15
2012 -$2.59M -$1.64M -171% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 -$956K +$104K +9.82% Jan 1, 2011 Dec 31, 2011 10-K 2013-04-03
2010 -$1.06M Jan 1, 2010 Dec 31, 2010 10-K/A 2012-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.